from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3052c/nrdI

LFCtreatmentdescriptionclass of inhibitor

0.278

Amikacinug/mL Amikacintranslation

0.758

Cap5-10ug/mL Capreomycintranslation

0.951

Rox10-50 ug/mL Roxithromycintranslation

0.279

SM2-5 ug/mL Streptomycintranslation

-0.084

Tet5-10 ug/mL Tetracyclinetranslation

-2.891

Rif0.2-5ug/mL Rifampicintranscription

-2.181

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.323

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.706

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.656

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.147

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.684

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.224

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.618

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.433

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.086

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.844

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.304

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.091

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.112

KCN5-20 ug/mL Potassium cyaniderespiration

-0.263

NaN30.2-2 mM Sodium aziderespiration

0.628

Nigericin50 uM Nigericinrespiration

0.220

TRC10-150 ug/mL Triclosanrespiration

0.602

TRZ10-25 ug/mL Thioridazinerespiration

0.098

Valinomycin0.5-10 uM Valinomycinrespiration

-0.161

ZnSO42 mM ZnSO4respiration

2.594

menadione6-10 ug/mL Menadionerespiration

-0.435

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.259

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.763

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.188

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.974

NRP_1Non-replicating persistence stage 1dosRassociated

0.099

Amp0.2mg/mL AmpicillincellWall

-0.309

Cephalexin20-100 ug/mL CephalexincellWall

-0.162

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.740

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.539

EMB10-20 ug/mL EthambutolcellWall

-0.192

Eta12-40 ug/mL EthionamidecellWall

-0.285

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.309

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.749

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.988

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.032

BZA0.12 mg/mL BenzamidearomaticAmides

0.535

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.349

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.510

H2O24 mM hydrogen peroxideDNAdamaging

0.677

Levo10 ug/mL LevofloxacinDNAdamaging

0.099

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.519

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.811

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.375

UVUV-irradiationDNAdamaging

2.967

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.699

Antimycin12.5-50 ug/mL Antimycin A?

-0.487

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.161

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.500

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.022

PA8240.2-2 ug/mL PA-824?

0.135

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.587

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.233

Verapamil50 uM Verapamil?

-0.254

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.518

methoxatin10-20 ug/mL Methoxatin?